Found 141 articles for: "acne"
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and Sex
August 2026 | Volume 25 | Issue 8 | Original Article | 708 | Copyright © August 2026
Background: Acne pathophysiology and presentation may differ by patient age or sex. In clinical trials, clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel...
Read MoreClinical Characteristics and Time to Onset of JAK-Inhibitor-Associated Acne: A Retrospective Chart Review Study
August 2026 | Volume 25 | Issue 8 | Original Article | 732 | Copyright © August 2026
Background: Acne is a common cutaneous adverse event associated with Janus kinase (JAK) inhibitors, with incidence varying across agents. Substantial increase in JAK inhibitor us...
Read MoreBenzoyl Peroxide Use is Not Associated with an Increased Risk of Skin Cancer: Findings from a Multicenter TriNetX Cohort Study
July 2026 | Volume 25 | Issue 7 | Editorials | e66 | Copyright © July 2026
A Novel Retinoid and Salicylic Acid Topical Treatment for Moderate-Severe Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 558 | Copyright © June 2026
Background: Advances in biotechnology have enabled highly effective, site-specific topical therapies for skin disease. Particle-based delivery systems can be engineered with tail...
Read MoreRandomized Controlled Study of Bacteriophages in Acne Reveals Efficacy and Novel Mechanism for Promoting Long-Term Skin Health
June 2026 | Volume 25 | Issue 6 | Original Article | 523 | Copyright © June 2026
Background: Acne is the most prevalent skin disease globally, with a significant burden and limited therapeutic innovation. Although it has a multifactorial etiology, Cutibacteri...
Read MoreEfficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 545 | Copyright © June 2026
Background: Clascoterone cream 1% is a topical androgen receptor inhibitor approved for the treatment of acne vulgaris in patients ≥12 years of age. The American Academy of De...
Read MoreEfficacy and Safety of Clascoterone Cream 1% and Clindamycin 1.2%/Benzoyl Peroxide 5% Gel Treatment in Patients With Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 537 | Copyright © June 2026
Background: Clascoterone cream 1% is a topical androgen receptor inhibitor approved to treat acne vulgaris in patients ≥12 years of age. The American Academy of Dermatology re...
Read MorePsychotherapeutic Interventions in Acne Vulgaris: A Call for Future Research
June 2026 | Volume 25 | Issue 6 | Features | e49 | Copyright © June 2026
Treating Acne Vulgaris and Scarring With Botulinum Toxin: A Systematic Review
June 2026 | Volume 25 | Issue 6 | Original Article | 508 | Copyright © June 2026
Background: Many treatments have been proposed for the treatment of acne vulgaris and acne scarring; however, few data exist regarding the efficacy of botulinum toxin A as a trea...
Read MoreBenzoyl Peroxide and Malignancy Risk: A Systematic Review and Meta-analysis of Over 4 Million Patients
May 2026 | Volume 25 | Issue 5 | Editorials | e43 | Copyright © May 2026
Practical Algorithm for Acne Treatment Integrating Skincare and Energy-Based Devices
February 2026 | Volume 25 | Issue 2 | Original Article | 111 | Copyright © February 2026
Background: Energy-based devices (EBDs) are increasingly used to manage acne and its sequelae. While literature supports the use of appropriate skin care for acne, few studies ad...
Read MoreEfficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex
February 2026 | Volume 25 | Issue 2 | Original Article | 119 | Copyright © February 2026
Acne vulgaris is an inflammatory skin condition affecting adolescents and adults of both sexes. Clascoterone cream 1% is indicated for the topical treatment of acne vulgaris in patients ≥12 ye...
Read MoreSkin Improvements in Acne Vulgaris Patients Using Gel-Matrix Moisturizer as a Complement to Topical Treatments
December 2025 | Volume 24 | Issue 12 | Original Article | 1239 | Copyright © December 2025
Background: A novel gel-matrix moisturizer was designed to 1) deliver immediate, long-lasting hydration benefits in a lightweight, non-greasy, noncomedogenic formula that is suit...
Read MoreNourishing the Skin: A Review of Diet's Role in Hidradenitis Suppurativa
November 2025 | Volume 24 | Issue 11 | Original Article | 1103 | Copyright © November 2025
Hidradenitis suppurativa (HS) is a complex skin condition influenced by both genetic and environmental factors. Increasing evidence points to diet as a key contributor to disease severity through...
Read MoreAssessing Cutibacterium Acnes Susceptibility With Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel Use: Six-Month Analysis
November 2025 | Volume 24 | Issue 11 | Original Article | 1106 | Copyright © November 2025
Background: The only approved triple-combination acne treatment – clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel - demonstrated efficacy/safety ...
Read MoreSafety and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Truncal Acne
August 2025 | Volume 24 | Issue 8 | Original Article | 803 | Copyright © August 2025
Background: Truncal acne is underdiagnosed and undertreated, and it can lead to scarring and postinflammatory hyperpigmentation. However, applying topical treatments to larger sk...
Read MoreNovel 2% Salicylic Acid Cleanser With Polymeric Cleansing Technology Treats Acne Without Compromising Skin Barrier
June 2025 | Volume 24 | Issue 6 | Original Article | 570 | Copyright © June 2025
Background: A novel acne cleanser containing 2% Salicylic acid (SA), Polymeric Cleansing Technology (PCT), and a microgel complex, was evaluated for its efficacy in treating mild...
Read MoreThe Impact on Acne Treatment Regimens if Benzoyl Peroxide-Containing Products are Removed From the Market
June 2025 | Volume 24 | Issue 6 | Features | 586 | Copyright © June 2025
Benzyl peroxide (BPO) has been an important component of many acne treatment regimens. However, an independent testing laboratory, Valisure, filed a Citizen’s Petition with the US Food and ...
Read MoreTreatment of Acne-Induced Macular Hyperpigmentation in Fitzpatrick Skin Types V - VI: A Scoping Review
June 2025 | Volume 24 | Issue 6 | Original Article | 579 | Copyright © June 2025
Acne-induced macular hyperpigmentation (AMH) is a common issue among patients with highly melanated skin, particularly those with Fitzpatrick Skin Types (FST) V - VI, which includes nonwhite pati...
Read MoreExploring the Potential Dermatological Benefits of CGRP Inhibition: A Case Report
June 2025 | Volume 24 | Issue 6 | Case Reports | 636 | Copyright © June 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
